Daiichi Sankyo, Inc. v. Seagen Inc.

Track this case

Case Number:

PGR2021-00030

Case Type:

PGR

Status:

Institution Denied

Petitioner:

Daiichi Sankyo, Inc.

Patent Owner:

Seagen Inc.

Patent Number:

10808039

Tech Center:

1600

  1. Filed: December 23, 2020 00:00

    Coverage

    1. July 18, 2022

      Seagen Gets PGR Nixed Under Fintiv In Rehearing Decision

      Seagen Inc. has persuaded the Patent Trial and Appeal Board on rehearing to deny a challenge from Daiichi Sankyo Inc. and AstraZeneca Pharmaceuticals LP to its cancer antibody patent, with the board saying the post-grant review is no longer warranted under the controversial Fintiv precedent.

    2 other articles on this case. View all »

    Stay ahead of the curve

    In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


    • Search PTAB cases and full-text documents.
    • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
    • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

    TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!